Literature DB >> 31253550

Antimicrobial stewardship impact on Pseudomonas aeruginosa susceptibility to meropenem at a tertiary pediatric institution.

Jeremy S Stultz1, Sandra R Arnold2, Chasity M Shelton3, Bindiya Bagga2, Kelley R Lee3.   

Abstract

An antimicrobial stewardship program was implemented throughout 2012 at a tertiary pediatric institution with guideline development preceding prospective audit and feedback starting in 2013. Meropenem use decreased over 62% during the next 5 years. Non-cystic fibrosis Pseudomonas aeruginosa isolate susceptibility to meropenem increased from 89% in 2011 to 98% in 2017 (P < .001) and correlated with meropenem use the preceding year (Rs: -0.78, P = .008).
Copyright © 2019 Association for Professionals in Infection Control and Epidemiology, Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial stewardship guidelines; Gram negative resistance; Guideline adherence; Microbial drug resistance; Prospective audit and feedback

Year:  2019        PMID： 31253550     DOI： 10.1016/j.ajic.2019.05.001

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN： 0196-6553            Impact factor:   2.918


  6 in total

1.  A Multicenter Analysis of Changes in Pediatric Antibiotic Susceptibilities Among Staphylococcus aureus and Pseudomonas aeruginosa Isolates: 2014-2018.

Authors:  Jeremy S Stultz; Emily Benefield; Kelley R Lee; Ferras Bashqoy; Amy L Pakyz
Journal:  J Pediatr Pharmacol Ther       Date:  2022-05-09

2.  The Impact of an Antibiotic Stewardship Program on the Consumption of Specific Antimicrobials and Their Cost Burden: A Hospital-wide Intervention.

Authors:  Dena Firouzabadi; Ali Akbari; Laleh Mahmoudi; Alireza Sepasian
Journal:  Risk Manag Healthc Policy       Date:  2020-09-23

Review 3.  It's Not Easy Being Green: A Narrative Review on the Microbiology, Virulence and Therapeutic Prospects of Multidrug-Resistant Pseudomonas aeruginosa.

Authors:  Payam Behzadi; Zoltán Baráth; Márió Gajdács
Journal:  Antibiotics (Basel)       Date:  2021-01-04

4.  Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study.

Authors:  Akihiro Shiroshita; Chisato Miyakoshi; Shunta Tsutsumi; Hiroshi Shiba; Chigusa Shirakawa; Kenya Sato; Shinya Matsushita; Yuya Kimura; Keisuke Tomii; Masahiro Ohgiya; Yuki Kataoka
Journal:  Sci Rep       Date:  2021-10-08       Impact factor: 4.379

5.  Evaluating the long-term impact of an antimicrobial stewardship programme in a Central London mixed medical and surgical intensive care unit.

Authors:  Shivani Singh; Rajiv Ark; Jason Tatlock; Sundhiya Mandalia; Christine Chung; Berge Azadian; Stephen Hughes; Nabeela Mughal; Luke S P Moore; Suveer Singh
Journal:  JAC Antimicrob Resist       Date:  2022-10-10

Review 6.  β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects.

Authors:  Karl A Glen; Iain L Lamont
Journal:  Pathogens       Date:  2021-12-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.